These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9278940)

  • 21. Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease.
    Parnetti L; Chiasserini D; Andreasson U; Ohlson M; Hüls C; Zetterberg H; Minthon L; Wallin AK; Andreasen N; Talesa VN; Blennow K
    Acta Neurol Scand; 2011 Aug; 124(2):122-9. PubMed ID: 20880294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human Acetylcholinesterase Activity.
    Obara K; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(10):1739-1746. PubMed ID: 28966245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.
    Arbel Y; Shenhar-Tsarfaty S; Waiskopf N; Finkelstein A; Halkin A; Revivo M; Berliner S; Herz I; Shapira I; Keren G; Soreq H; Banai S
    Mol Med; 2014 Feb; 20(1):38-45. PubMed ID: 24395570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    Dingova D; Fazekas T; Okuliarova P; Strbova J; Kucera M; Hrabovska A
    J Alzheimers Dis; 2016; 51(3):801-13. PubMed ID: 26890780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinergic Crisis Owing to Distigmine Bromide Complicated by Hyperosmolar Hyperglycemic State.
    Kotake K; Tone A; Watanabe S; Senoo M; Kaneto M; Imai Y; Teshigawara S; Kawakami Y; Nakatou T
    Intern Med; 2021 Jul; 60(14):2251-2254. PubMed ID: 33583891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexpected cholinergic crisis caused by distigmine bromide: A case report.
    Sera T; Kusunoki S; Shime N
    Medicine (Baltimore); 2022 Nov; 101(47):e31677. PubMed ID: 36451415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On-site analysis of acetylcholinesterase and butyrylcholinesterase activity with the ChE check mobile test kit-Determination of reference values and their relevance for diagnosis of exposure to organophosphorus compounds.
    Worek F; Schilha M; Neumaier K; Aurbek N; Wille T; Thiermann H; Kehe K
    Toxicol Lett; 2016 May; 249():22-8. PubMed ID: 27033775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation.
    Yang Y; Cheng X; Liu W; Chou G; Wang Z; Wang C
    J Ethnopharmacol; 2015 Jun; 168():279-86. PubMed ID: 25862961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
    Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
    Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality.
    Ben Assayag E; Shenhar-Tsarfaty S; Ofek K; Soreq L; Bova I; Shopin L; Berg RM; Berliner S; Shapira I; Bornstein NM; Soreq H
    Mol Med; 2010; 16(7-8):278-86. PubMed ID: 20464061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
    Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
    Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer's disease].
    Zhuravin IА; Nalivaeva NN; Kozlova DI; Kochkina EG; Fedorova YB; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):110-117. PubMed ID: 26978503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the organophosphate fenthion for control of the red-billed quelea Quelea quelea on cholinesterase and haemoglobin concentrations in the blood of target and non-target birds.
    Cheke RA; McWilliam AN; Mbereki C; van der Walt E; Mtobesya B; Magoma RN; Young S; Eberly JP
    Ecotoxicology; 2012 Oct; 21(7):1761-70. PubMed ID: 22539115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Three cases of cholinergic crisis in which serum distigmine bromide concentrations were measured].
    Onodera M; Fujino Y; Inoue Y; Endo S; Fujita Y
    Chudoku Kenkyu; 2008 Jan; 21(1):75-81. PubMed ID: 18277557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
    Reale M; Costantini E; Di Nicola M; D'Angelo C; Franchi S; D'Aurora M; Di Bari M; Orlando V; Galizia S; Ruggieri S; Stuppia L; Gasperini C; Tata AM; Gatta V
    Sci Rep; 2018 Jan; 8(1):1319. PubMed ID: 29358722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
    Minic J; Chatonnet A; Krejci E; Molgó J
    Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis.
    Battisti V; Bagatini MD; Maders LD; Chiesa J; Santos KF; Gonçalves JF; Abdalla FH; Battisti IE; Schetinger MR; Morsch VM
    Biomed Pharmacother; 2012 Jun; 66(4):249-55. PubMed ID: 22560633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.